Official Journal of Research Center for Gastroenterology and Liver Diseases
Authors
Primary liver cancer is one of the most common and deadly malignant neoplasms worldwide. The incidence and mortality rates for hepatocellular carcinoma (HCC) are virtually identical, reflecting the poor overall survival of patients with this kind of tumor. Effective therapies mostly achieved if the HCC diagnosis is made at early stages of the tumor. Surveillance tests include serologic and radiologic examinations.
In this review, an overview of biomarkers for the diagnosis of HCC and future challenges in this popular field has been presented.
Serum tumor markers, such as alpha-fetoprotein (AFP) and des-gammacarboxy prothrombin (DCP) are commonly used for the surveillance, but their roles have been intensely debated despite the existence of sensitive radiologic tests. Most HCC-related cancer biomarkers are involved in chronic inflammation and cancer. These biomarkers, according to their biologic characteristics are primarily divided into three groups including onco-foetal protein, stress protein, and post-translational modification.
Because of the limitations of traditional HCC biomarkers, exploration for novel biomarkers for the diagnosis of HCC is an evolving process.
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Heidari Z, Moudi B. Application of Tumor Biomarkers as Screening Tools in Early Detection of Hepatocellular Carcinoma. Gene Cell Tissue. 2015;2(4):e33012. doi: https://doi.org/10.17795/gct-33012
Davarpanah AH. Diagnosis and Staging of Hepatocellular Carcinoma. I J Radiol. 2017;14(Special Issue):e48398. doi: https://doi.org/10.5812/iranjradiol.48398
Karami A, Alavian S, Najafi A, Hosseini M. Molecular Aspects of Hepatocellular Carcinoma Caused by Hepatitis C Virus. Hepat Mon. 2006;6(2):. doi:
Fouad SA, Mohamed NAG, Fawzy MW, Moustafa DA. Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma. Hepat Mon. 2015;15(9):e30753. doi: https://doi.org/10.5812/hepatmon.30753
Moradi N, Paryan M, Khansarinejad B, Sarmadian H, Mondanizadeh M. Plasma Level of miR-5193 as a Novel Biomarker for Diagnosis of HBV-Related Hepatocellular Carcinoma. Hepat Mon. 2019;19(2):e84455. doi: https://doi.org/10.5812/hepatmon.84455
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 2 hours ago
Last Update: 8 hours ago
Last Update: 5 days ago
